• / Free eNewsletters & Magazine
  • / My Account
Home>Why Retirement Funds Fall Short

Why Retirement Funds Fall Short

Morningstar Articles

Tue, 2 Apr 2013

Cephalon CEPH announced Monday that Gabitril did not meet the primary endpoints in a Phase III study for generalized anxiety disorder (GAD). We're sticking with our fair value estimate of $44 per share, as we had assumed only a modest increase in Gabitril

Related Videos

  1. Practical Strategies for Today's Bond Market

    The outlook for bonds is just as cloudy as ever, but Morningstar's Miriam Sjoblom and Marta Norton offer helpful tips for setting the right expectations and creating a game plan in today's challenging bond market.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.